You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

p24

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HIV Trial in Rochester (HIV p17/p24:Ty-VLP, Aluminum hydroxide)

Completed
  • HIV Infections
  • HIV p17/p24:Ty-VLP
  • Aluminum hydroxide
  • Rochester, New York
    Univ. of Rochester AVEG
Oct 28, 2021

HIV Trial in Washington, Hershey (Ampligen)

Completed
  • HIV Infections
  • Washington, District of Columbia
  • +1 more
Oct 27, 2021

Access HIV Ag/Ab Combo Assay - European Union Clinical Trial

Active, not recruiting
  • HIV I Infection
  • HIV-2 Infection
  • Access HIV_blood donor
  • +7 more
  • Bois-Guillaume, France
  • +4 more
Jun 23, 2022

HIV, HIV Seronegativity Trial in United States (HIV p24/MF59 Vaccine, ALVAC-HIV MN120TMG (vCP205), ALVAC-RG Rabies Glycoprotein

Completed
  • HIV Infections
  • HIV Seronegativity
  • HIV p24/MF59 Vaccine
  • +3 more
  • Birmingham, Alabama
  • +6 more
Oct 27, 2021

Asthma Trial in Gainesville, Iowa City, Madison (Formatris 24µg, Formatris 12µg, Foradil P 24µg)

Completed
Has Results
  • Asthma
  • Formatris 24µg
  • +3 more
  • Gainesville, Florida
  • +2 more
Feb 4, 2022

A 24-month Real Life PErsistence Efficacy and Safety Study in

Recruiting
  • Inflammatory Bowel Diseases
  • Subcutaneous infliximab CT-P13 Remsima®SC
  • Grenoble, France
    Nicolas Mathieu
Aug 2, 2022

Pregnancy Related, Infertility, Female Trial in Abu Dhabi, Al Ain, Dubai (diagnostic test, drug, procedure)

Not yet recruiting
  • Pregnancy Related
  • Infertility, Female
  • Transvaginal ultrasound
  • +7 more
  • Abu Dhabi, United Arab Emirates
  • +2 more
Jul 24, 2023

Pneumococcal Vaccines Trial in United States (0.5 ml dose of 1.1 mcg VAX-24, 0.5 ml dose of PCV15, 0.5 ml dose of 2.2 mcg

Recruiting
  • Pneumococcal Vaccines
  • 0.5 ml dose of 1.1 mcg VAX-24
  • +3 more
  • Jonesboro, Arkansas
  • +25 more
May 4, 2023

Onychomycosis of Toenail Trial in London (Swift Microwave treatment - weekly x 4wks, Swift Microwave treatment - Every other

Not yet recruiting
  • Onychomycosis of Toenail
  • Swift Microwave treatment - weekly x 4wks
  • +2 more
  • London, Ontario, Canada
    Mediprobe Research Inc
Dec 29, 2022

COPD Trial in Dublin 24 (Smartphone application self-management programme)

Active, not recruiting
  • Chronic Obstructive Pulmonary Disease
  • Smartphone application self-management programme
  • Dublin 24, Ireland
    Tallaght University Hospital
Nov 2, 2022

Rhinitis, Allergic, Perennial Trial (mometasone furoate)

Completed
Has Results
  • Rhinitis, Allergic, Perennial
  • mometasone furoate
  • (no location specified)
Feb 7, 2022

Primary Sclerosing Cholangitis Trial in Germany, Israel, United Kingdom (CM-101, Placebo)

Recruiting
  • Primary Sclerosing Cholangitis
  • CM-101
  • Placebo
  • Bonn, Germany
  • +20 more
Sep 1, 2021

High Ischemic Risk Trial in Seoul (Ticagrelor-based dual-antiplatelet therapy, Clopidogrel-based dual-antiplatelet therapy)

Not yet recruiting
  • High Ischemic Risk
  • Ticagrelor-based dual-antiplatelet therapy
  • Clopidogrel-based dual-antiplatelet therapy
  • Seoul, Korea, Republic of
    Severance Hospital, Yonsei University Health System
Aug 3, 2021

Nasal Polyps Trial (Mometasone Furoate Nasal Spray, Placebo)

Completed
  • Nasal Polyps
  • Mometasone Furoate Nasal Spray
  • Placebo
  • (no location specified)
Feb 7, 2022

Squamous Cell Carcinoma of Head and Neck Trial in Italy (Nivolumab 240 MG in 24 ML Injection)

Completed
  • Squamous Cell Carcinoma of Head and Neck
  • Nivolumab 240 MG in 24 ML Injection
  • Bergamo, Italy
  • +22 more
Apr 4, 2023

Plasma Biomarkers P-DAC, V1

Terminated
  • Pancreatic Ductal Adenocarcinoma
    • Bracken Rd, Sandyford Industrial Estate, Dublin 18, Ireland
    • +8 more
    Jan 14, 2022

    Hepatitis C, Chronic Trial in Taiwan (PEGASYS 180 µg Q1W, P1101 180 µg Q1W, 48 doses, P1101 270µg Q1W, 48 doses)

    Completed
    • Hepatitis C, Chronic
    • PEGASYS 180 µg Q1W
    • +3 more
    • Changhua, Taiwan
    • +12 more
    Oct 7, 2021

    Spot Urine Sample for Monoclonal Components Detection in

    Recruiting
    • Multiple Myeloma
    • Detection of monoclonal component
    • Annecy, France
    • +19 more
    Jul 20, 2022

    Advanced Solid Tumor, MSI-H/dMMR Tumors, Cutaneous Squamous Cell Carcinoma Trial in Worldwide (INCB099280)

    Recruiting
    • Advanced Solid Tumor
    • +11 more
    • Boston, Massachusetts
    • +30 more
    Dec 1, 2022

    People Who Have Genetic Changes and Features of Autism: Simons

    Recruiting
    • 16P11.2 Deletion Syndrome
    • +184 more
      • New York, New York
      • +1 more
      Jan 6, 2023

      COVID-19 Trial in Russian Federation (Tyrosyl-D-alanyl-glycyl-phenylalanyl-leucyl-arginine succinate intramuscularly,

      Completed
      • COVID-19
      • Tyrosyl-D-alanyl-glycyl-phenylalanyl-leucyl-arginine succinate intramuscularly
      • +2 more
      • Cheboksary, Russian Federation
      • +9 more
      Dec 19, 2022

      Cystic Fibrosis Trial in Canada, United States (LUM/IVA)

      Active, not recruiting
      • Cystic Fibrosis
      • Birmingham, Alabama
      • +22 more
      Nov 30, 2022

      Obesity, Morbid, Bariatric Surgery, Adolescent Trial in Aurora (Phentermine, Immediate Release Topiramate, Placebo for

      Completed
      • Obesity, Morbid
      • +4 more
      • Aurora, Colorado
        Children's Hospital Colorado
      Mar 7, 2022

      Brodalumab in Plaque Psoriasis to Understand Impact on Quality

      Recruiting
      • Psoriasis
      • Brodalumab
      • Matched cohort
      • Calgary, Alberta, Canada
      • +33 more
      Oct 8, 2022

      Vascular Dementia Trial in Russian Federation (Prospecta, Placebo)

      Completed
      • Vascular Dementia
      • Arkhangelsk, Russian Federation
      • +32 more
      Jan 20, 2023